NEW YORK (GenomeWeb) – CombiMatrix is facing a delisting of its stock from the Nasdaq for failing to meet the stock exchange's $1 minimum bid price, the molecular diagnostics firm disclosed last week in a filing with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.